腫瘍学コンパニオン診断の世界市場は、2022年に約31億米ドルと評価され、予測期間2023年から2030年にかけて12.9%以上の健全な成長率で成長すると予測されています。
腫瘍学コンパニオン診断（CDx）は、患者の腫瘍における特定の特徴や分子変化を同定するために使用される医療検査やバイオマーカーの一種です。これらの特性は、しばしば特定の標的療法やがんの治療に対する患者の反応の可能性に関連します。腫瘍学コンパニオン診断の主な目的は、医療従事者ががん患者に対してより個別化された効果的な治療方針を決定する手助けをすることです。標的を絞ったがん治療やオーダーメイドの薬剤に対する需要の急増、製薬産業への投資の増加、コンパニオン診断薬の承認率の上昇が、世界中で市場の需要を促進している最も顕著な要因となっています。
さらに、高齢化や不健康なライフスタイルなどの要因により、がんの罹患率は世界的に上昇しています。このため、腫瘍学コンパニオン診断に対する需要が高まっています。世界保健機関（WHO）によると、2020年には世界で約1,930万人の新規がん症例が記録されたと推定されており、この症例数は増加し、2040年には3,020万人に達すると予測されています。さらに、診断事業体と製薬事業体との提携の増加や、研究開発活動への投資の増加は、予測期間中に様々な有利な機会をもたらします。しかし、開発・検査コストの高さと規制上の課題が、2023〜2030年の予測期間を通じて市場の成長を妨げています。
腫瘍学コンパニオン診断の世界市場調査において考慮された主要地域は、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカです。北アメリカは、精密医療における進歩の高まり、標的がん治療の開発の増加、標的治療と個別化医療に対する製薬業界の焦点の高まりにより、2022年の市場を支配しました。一方、アジア太平洋地域は予測期間中最も高いCAGRで成長すると予想されています。精密医療やゲノム研究を推進する政府や医療業界のイニシアチブの増加、診断技術やツールの継続的な進歩がコンパニオン診断の開発・改良に寄与し、同地域全体の市場需要を大きく押し上げています。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Oncology Companion Diagnostic Market, by Region, 2020-2030 (USD Billion)
1.2.2. Oncology Companion Diagnostic Market, by Offerings, 2020-2030 (USD Billion)
1.2.3. Oncology Companion Diagnostic Market, by Technology, 2020-2030 (USD Billion)
1.2.4. Oncology Companion Diagnostic Market, by Disease Type, 2020-2030 (USD Billion)
1.2.5. Oncology Companion Diagnostic Market, by End-use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Oncology Companion Diagnostic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Oncology Companion Diagnostic Market Dynamics
3.1. Oncology Companion Diagnostic Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Surge in demand for targeted cancer treatment and tailored drugs
3.1.1.2. Rising incidence of cancer
3.1.2. Market Challenges
3.1.2.1. High cost of development and testing
3.1.2.2. Regulatory challenges
3.1.3. Market Opportunities
3.1.3.1. Increasing collaborations between diagnostic and pharma entities
3.1.3.2. Growing investment in the research and development activities
Chapter 4. Global Oncology Companion Diagnostic Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Oncology Companion Diagnostic Market, by Offerings
5.1. Market Snapshot
5.2. Global Oncology Companion Diagnostic Market by Offerings, Performance - Potential Analysis
5.3. Global Oncology Companion Diagnostic Market Estimates & Forecasts by Offerings 2020-2030 (USD Billion)
5.4. Oncology Companion Diagnostic Market, Sub Segment Analysis
5.4.1. Instrument
5.4.2. Consumables
5.4.3. Software
5.4.4. Services
Chapter 6. Global Oncology Companion Diagnostic Market, by Technology
6.1. Market Snapshot
6.2. Global Oncology Companion Diagnostic Market by Technology, Performance - Potential Analysis
6.3. Global Oncology Companion Diagnostic Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
6.4. Oncology Companion Diagnostic Market, Sub Segment Analysis
6.4.1. Polymerase Chain Reaction (PCR)
6.4.2. Next-Generation Sequencing (NGS)
6.4.3. Immunohistochemistry (IHC)
6.4.4. In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization (FISH)
6.4.5. Other Technologies
Chapter 7. Global Oncology Companion Diagnostic Market, by Disease Type
7.1. Market Snapshot
7.2. Global Oncology Companion Diagnostic Market by Disease Type, Performance - Potential Analysis
7.3. Global Oncology Companion Diagnostic Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
7.4. Oncology Companion Diagnostic Market, Sub Segment Analysis
7.4.1. Breast cancer
7.4.2. Non-small cell lung cancer
7.4.3. Colorectal cancer
7.4.4. Leukemia
7.4.5. Melanoma
7.4.6. Prostate cancer
7.4.7. Others
Chapter 8. Oncology Companion Diagnostic Market, by End-use
8.1. Market Snapshot
8.2. Global Oncology Companion Diagnostic Market by End-use, Performance - Potential Analysis
8.3. Global Oncology Companion Diagnostic Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
8.4. Oncology Companion Diagnostic Market, Sub Segment Analysis
8.4.1. Hospital
8.4.2. Pathology/Diagnostic laboratory
8.4.3. Academic medical center
Chapter 9. Global Oncology Companion Diagnostic Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Oncology Companion Diagnostic Market, Regional Market Snapshot
9.4. North America Oncology Companion Diagnostic Market
9.4.1. U.S. Oncology Companion Diagnostic Market
9.4.1.1. Offerings breakdown estimates & forecasts, 2020-2030
9.4.1.2. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.3. Disease Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Oncology Companion Diagnostic Market
9.5. Europe Oncology Companion Diagnostic Market Snapshot
9.5.1. U.K. Oncology Companion Diagnostic Market
9.5.2. Germany Oncology Companion Diagnostic Market
9.5.3. France Oncology Companion Diagnostic Market
9.5.4. Spain Oncology Companion Diagnostic Market
9.5.5. Italy Oncology Companion Diagnostic Market
9.5.6. Rest of Europe Oncology Companion Diagnostic Market
9.6. Asia-Pacific Oncology Companion Diagnostic Market Snapshot
9.6.1. China Oncology Companion Diagnostic Market
9.6.2. India Oncology Companion Diagnostic Market
9.6.3. Japan Oncology Companion Diagnostic Market
9.6.4. Australia Oncology Companion Diagnostic Market
9.6.5. South Korea Oncology Companion Diagnostic Market
9.6.6. Rest of Asia Pacific Oncology Companion Diagnostic Market
9.7. Latin America Oncology Companion Diagnostic Market Snapshot
9.7.1. Brazil Oncology Companion Diagnostic Market
9.7.2. Mexico Oncology Companion Diagnostic Market
9.8. Middle East & Africa Oncology Companion Diagnostic Market
9.8.1. Saudi Arabia Oncology Companion Diagnostic Market
9.8.2. South Africa Oncology Companion Diagnostic Market
9.8.3. Rest of Middle East & Africa Oncology Companion Diagnostic Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Agilent Technologies, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Illumina, Inc.
10.3.3. QIAGEN N.V.
10.3.4. Thermo Fisher Scientific, Inc.
10.3.5. F. Hoffmann-La Roche Ltd.
10.3.6. ARUP Laboratories
10.3.7. Abbott Laboratories
10.3.8. Myriad Genetics, Inc.
10.3.9. bioMérieux SA
10.3.10. Invivoscribe, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Oncology Companion Diagnostic Market, report scope
TABLE 2. Global Oncology Companion Diagnostic Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Oncology Companion Diagnostic Market estimates & forecasts by Offerings 2020-2030 (USD Billion)
TABLE 4. Global Oncology Companion Diagnostic Market estimates & forecasts by Technology 2020-2030 (USD Billion)
TABLE 5. Global Oncology Companion Diagnostic Market estimates & forecasts by Disease Type 2020-2030 (USD Billion)
TABLE 6. Global Oncology Companion Diagnostic Market estimates & forecasts by End-use 2020-2030 (USD Billion)
TABLE 7. Global Oncology Companion Diagnostic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Oncology Companion Diagnostic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Oncology Companion Diagnostic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Oncology Companion Diagnostic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Oncology Companion Diagnostic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Oncology Companion Diagnostic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Oncology Companion Diagnostic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Oncology Companion Diagnostic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Oncology Companion Diagnostic Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Oncology Companion Diagnostic Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Oncology Companion Diagnostic Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Oncology Companion Diagnostic Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Oncology Companion Diagnostic Market
TABLE 72. List of primary sources, used in the study of global Oncology Companion Diagnostic Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Oncology Companion Diagnostic Market, research methodology
FIG 2. Global Oncology Companion Diagnostic Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Oncology Companion Diagnostic Market, key trends 2022
FIG 5. Global Oncology Companion Diagnostic Market, growth prospects 2023-2030
FIG 6. Global Oncology Companion Diagnostic Market, porters 5 force model
FIG 7. Global Oncology Companion Diagnostic Market, pest analysis
FIG 8. Global Oncology Companion Diagnostic Market, value chain analysis
FIG 9. Global Oncology Companion Diagnostic Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Oncology Companion Diagnostic Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Oncology Companion Diagnostic Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Oncology Companion Diagnostic Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Oncology Companion Diagnostic Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Oncology Companion Diagnostic Market, regional snapshot 2020 & 2030
FIG 15. North America Oncology Companion Diagnostic Market 2020 & 2030 (USD Billion)
FIG 16. Europe Oncology Companion Diagnostic Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Oncology Companion Diagnostic Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Oncology Companion Diagnostic Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Oncology Companion Diagnostic Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
